LFMD - LifeMD, Inc. Stock Analysis

Stock Taper

OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

LFMD

LIFEMD, INC.

NASDAQ

$2.63

▼ DOWN 0.75% (-0.02)

KEY STATISTICS

Market Cap$128.40 M

52w High$6.68

52w Low$2.56

Dividend Yield—

Frequency—

P/E-5.26

Volume620.10K

Shares Out.48.36M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Justin Schreiber

COMPENSATION 2026

Salary$180,000

Stock Awards$0

Incentive Plan Pay$0

All Other Comp.$0

Total$180,000

ABOUT

SECTOR

Healthcare

WENT PUBLIC

January 29, 2008

METHOD OF GOING PUBLIC

SPAC

FULL TIME EMPLOYEES

350

PRICE TARGET

Target High$9.00

Target Low$5.00

Target Median$7.00

Target Consensus$7.00

UPCOMING EARNINGS

DateNov 11, 2026

DayWednesday

Rev. Est.$48.87M

NOV

WED

SPLIT RECORD

DATE	TYPE	RATIO
2020-10-14	Reverse	1:5

ETFS HOLDING THIS STOCK

ETFS HOLDING

LISTED HERE

RANKED BY POSITION SIZE

INSTITUTIONAL OWNERSHIP

SHARES OWNED

32.72%

HOLDERS

172

TOP 8 OF 172 · RANKED BY POSITION SIZE

Blackrock, Inc.

3.0M sh

$12.53M

Federated Hermes, Inc.

Renaissance Technologies LLC

Royce & Associates LP

1.2M sh

$4.34M

PRICE

$2.63 ▼ DOWN 0.75% (−$0.02)

OVERLAYS

About LifeMD, Inc.

https://www.lifemd.com ↗

LifeMD, Inc. is a New York-based telehealth company offering virtual care, prescriptions, and health products across various specialties via direct-to-consumer and partner channels.

INDUSTRY

Medical - Healthcare Information Services

A PRODUCT LIFEMD, INC. IS KNOWN FOR

Wegovy® pill

LifeMD offers the first FDA-approved oral GLP-1 medication for weight management through its telehealth platform, enhancing its Weight Management Program with accessible, cutting-edge branded treatments.

COMPETITORS

COMPETITOR

LifeMD in 2025

SENTIMENT: − NEGATIVE

LEGAL · AUGUST 2025

LifeMD Stock Plummets 44% After Q2 2025 Earnings Miss and Guidance Cut, Sparking Securities Fraud Lawsuits

On August 5, 2025, LifeMD announced disappointing second-quarter financial results, missing analyst expectations for both earnings and revenue. The company also significantly lowered its full-year 2025 guidance, citing rising customer acquisition costs and patient refunds, which led to a 44% crash in its stock price on August 6 and triggered multiple securities fraud class-action lawsuits.

MARKET EXPANSION · AUGUST 2025 · IN PROGRESS

LifeMD Diversifies into High-Growth Verticals with Nationwide Behavioral Health Launch and Women's Health Acquisition

In a significant strategic move during the second quarter of 2025, LifeMD expanded its platform by launching a nationwide behavioral health service and acquiring a virtual women's health brand. This initiative is designed to diversify the company's revenue streams and broaden its clinical scope beyond its core men's health and weight management services into large, underserved healthcare markets.